Joseph P. Lucia & Associates’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,024
Closed -$2K 337
2022
Q2
$2K Hold
1,024
﹤0.01% 397
2022
Q1
$3K Buy
+1,024
New +$3.6K ﹤0.01% 393
2021
Q4
Sell
-1,024
Closed -$7K 415
2021
Q3
$7K Hold
1,024
﹤0.01% 410
2021
Q2
$8K Hold
1,024
﹤0.01% 404
2021
Q1
$7K Sell
1,024
-1,600
-61% -$10.6K ﹤0.01% 400
2020
Q4
$5K Buy
+2,624
New +$1.26K ﹤0.01% 392
2020
Q3
Sell
-1,024
Closed 333
2020
Q2
$0 Hold
1,024
﹤0.01% 490
2020
Q1
$0 Hold
1,024
﹤0.01% 480
2019
Q4
$1K Sell
1,024
-83
-7% -$83 ﹤0.01% 431
2019
Q3
$3K Sell
1,107
-1
-0.1% -$12 ﹤0.01% 399
2019
Q2
$13K Buy
1,108
+1,091
+6,418% +$12.3K 0.01% 279
2019
Q1
$5.73K Buy
+17
New +$145 0.43% 46

Other funds holding OCGN

Joseph P. Lucia & Associates's OCGN Position: Q3 2022 in Review

Joseph P. Lucia & Associates sold out of Ocugen (OCGN) in Q3 2022, closing a stake of 1,024 shares — an estimated $2K sold.

Joseph P. Lucia & Associates first reported a position in OCGN in Q1 2019 and held it in 12 quarters. The position peaked at $13K in Q2 2019. 128 funds tracked by Wall St. Rank hold OCGN as of Q3 2022.

  • Joseph P. Lucia & Associates reported no remaining Ocugen position as of Q3 2022 after selling out during the quarter.
  • Joseph P. Lucia & Associates sold 1,024 Ocugen shares in Q3 2022, an estimated $2K.
  • Joseph P. Lucia & Associates first reported a position in Ocugen in Q1 2019 and held it in 12 quarters.
  • Joseph P. Lucia & Associates's Ocugen position peaked at $13K in Q2 2019.
  • 128 funds tracked by Wall St. Rank held Ocugen as of Q3 2022.

Based on Joseph P. Lucia & Associates's 13F filing for Q3 2022, filed 28 Oct 2022.